Easy Solutions has raised $11 million in Series B funding for technology that protects companies through the entire life cycle of computerized fraud–from planning to launching to cashing in on an attack–as it prepares to expand from Latin America into the global market. The company was founded in Bogota, Colombia, by Chief Executive Ricardo Villadiego, a computer security specialist, along with his wife and a friend.
China Renaissance Capital Investment is raising a $100 million venture capital fund in what will be the firm’s first standalone investment vehicle. Known as Huaxing Capital Partners LP, the venture fund will be invested in technology, media and telecommunications companies across the mainland, according to a person familiar with the fundraising process. The firm will tap international, including U.S., investors.
Also in today’s VentureWire, Drugmakers targeting Alzheimer’s disease have largely zeroed in on plaques forming in the brain, but Acumen Pharmaceuticals believes it’s found a better target. The company just raised $700,000 in the first of a three-tranche Series A round that will total $20 million…Tiger Global Management has led a $50 million investment to buy a secondary stake in Automattic, the company behind the open-source blogging software known as WordPress, as new money continues to flow into Web publishing tools…and Evoke Pharma and Prosensa Holding registered Friday with U.S. securities regulators for planned initial public offerings, joining a growing list of companies eager to test the appetite of public markets for clinical-stage drug developers.
(VentureWire is a daily newsletter with comprehensive analysis of all the investments, deals and personnel moves involving startups and their venture backers. For a two-week trial, visit our homepage, scroll to the bottom and click “try for free.”)